PetMed Express EBIT 2010-2024 | PETS
PetMed Express ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
PetMed Express Annual EBIT
(Millions of US $) |
| 2024 |
$-8 |
| 2023 |
$6 |
| 2022 |
$24 |
| 2021 |
$31 |
| 2020 |
$31 |
| 2019 |
$46 |
| 2018 |
$52 |
| 2017 |
$37 |
| 2016 |
$32 |
| 2015 |
$28 |
| 2014 |
$28 |
| 2013 |
$27 |
| 2012 |
$26 |
| 2011 |
$33 |
| 2010 |
$41 |
| 2009 |
$34 |
PetMed Express Quarterly EBIT
(Millions of US $) |
| 2024-12-31 |
$0 |
| 2024-09-30 |
$1 |
| 2024-06-30 |
$4 |
| 2024-03-31 |
$-4 |
| 2023-12-31 |
$-3 |
| 2023-09-30 |
$1 |
| 2023-06-30 |
$-2 |
| 2023-03-31 |
$0 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$4 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$6 |
| 2021-12-31 |
$5 |
| 2021-09-30 |
$8 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$9 |
| 2020-09-30 |
$10 |
| 2020-06-30 |
$9 |
| 2020-03-31 |
$9 |
| 2019-12-31 |
$8 |
| 2019-09-30 |
$8 |
| 2019-06-30 |
$6 |
| 2019-03-31 |
$8 |
| 2018-12-31 |
$9 |
| 2018-09-30 |
$13 |
| 2018-06-30 |
$16 |
| 2018-03-31 |
$14 |
| 2017-12-31 |
$11 |
| 2017-09-30 |
$12 |
| 2017-06-30 |
$14 |
| 2017-03-31 |
$12 |
| 2016-12-31 |
$8 |
| 2016-09-30 |
$8 |
| 2016-06-30 |
$10 |
| 2016-03-31 |
$9 |
| 2015-12-31 |
$8 |
| 2015-09-30 |
$7 |
| 2015-06-30 |
$9 |
| 2015-03-31 |
$8 |
| 2014-12-31 |
$8 |
| 2014-09-30 |
$4 |
| 2014-06-30 |
$8 |
| 2014-03-31 |
$7 |
| 2013-12-31 |
$7 |
| 2013-09-30 |
$7 |
| 2013-06-30 |
$7 |
| 2013-03-31 |
$7 |
| 2012-12-31 |
$7 |
| 2012-09-30 |
$6 |
| 2012-06-30 |
$6 |
| 2012-03-31 |
$6 |
| 2011-12-31 |
$6 |
| 2011-09-30 |
$6 |
| 2011-06-30 |
$8 |
| 2011-03-31 |
$6 |
| 2010-12-31 |
$7 |
| 2010-09-30 |
$8 |
| 2010-06-30 |
$12 |
| 2010-03-31 |
$10 |
| 2009-12-31 |
$8 |
| 2009-09-30 |
$10 |
| 2009-06-30 |
$13 |
| 2009-03-31 |
$9 |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
INTERNET COMMERCE |
$0.072B |
$0.281B |
|
PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. The Company markets its products through national advertising campaigns, which aim to increase the recognition of the `1-800-PetMeds` brand name, and `PetMeds` family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. The majority of the Company's sales are to residents in the United States. The Company's corporate headquarters and distribution facility are located in Delray Beach, Florida.
|
